NCT01772680View on ClinicalTrials.gov

Zinc and Diabetes in Patients With Thalassemia: a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

May 31, 2015

Conditions
Thalassemia
Interventions
DIETARY_SUPPLEMENT

Zinc Supplementation

25 mg elemental zinc taken as zinc sulfate in capsule form taken daily for 3 months

Trial Locations (1)

94609

Children's Hospital & Research Center Oakland, Oakland

All Listed Sponsors
lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT01772680 - Zinc and Diabetes in Patients With Thalassemia: a Pilot Study | Biotech Hunter | Biotech Hunter